american diabetes association pancreatitis glp-1 receptor agonist history Frontiers A Comprehensive Review of the
Description
Obesity coverage by US payors should increase as prices fall, but in many European countries, particularly Germany, France and Spain, the issue lies with obesity being regarded as a lifestyle disease, and so something that should not be treated with drugs
Sleep Apnea J 12(1):2334 [Google Scholar] 33.Kow CS, Hasan SS, Naing L, Merchant HA (2025) Effects of GLP-1 receptor agonists on obstructive sleep apnea severity: a systematic review and meta-analysis of clinical trials
The study, published in Annals of Internal Medicine , found that people with type 2 diabetes who started taking GLP-1 receptor agonists were slightly more likely to develop ischemic optic neuropathy (ION) than those prescribed other diabetes drugs
Katkenov N., Mukhatayev Z., Kozhakhmetov S., Sailybayeva A., Bekbossynova M., Kushugulova A
writingoriginal draft preparation, M.A
